logo

ACXP

Acurx·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ACXP fundamentals

Acurx (ACXP) released its earnings on Nov 12, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -1.23 (YoY -623.53%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-1.23
-623.53%
Report date
Nov 12, 2025
ACXP Earnings Call Summary for Q3,2025
  • Nasdaq Compliance Achieved: Regained listing with $1 bid price and $2.5M equity threshold.
  • Patent Portfolio Expanded: 8 global patents, including microbiome-sparing class effect validation.
  • Cash Growth: $5.9M (vs. $3.7M YoY) with $9M equity line remaining.
  • Cost Efficiency: R&D down 67%, G&A down 28%, net loss halved to $2M.
  • Phase III Readiness: Salvage trial expected soon, targeting secondary C. diff market.
EPS
Revenue

Revenue & Expenses

Key Indicators

Acurx (ACXP) key financial stats and ratios, covering profitability, financial health, and leverage.
Acurx (ACXP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Acurx (ACXP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Acurx (ACXP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Acurx (ACXP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Acurx (ACXP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield